GDF15 Antikörper (N-Term)
Kurzübersicht für GDF15 Antikörper (N-Term) (ABIN5540380)
Target
Alle GDF15 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 30-194, N-Term
-
Spezifität
- Recognizes Human Macrophage Inhibitory Cytokine-1 (MIC-1). Other species not tested.
-
Aufreinigung
- Affinity Chromatography on Protein G
-
Immunogen
- Genetic immunisation with cDNA encoding amino acids 30-194 (N-term) of MIC-1 proprotein.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Cell based ELISA with intakt, transiently transfected cells: 1/200-1/400. Flow Cytometry: 1.2 μg/10 6 cells.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Phosphate buffered saline, pH 7.2 without preservatives
-
Konservierungsmittel
- Without preservative
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
-
Haltbarkeit
- 12 months
-
-
- GDF15 (Growth Differentiation Factor 15 (GDF15))
-
Andere Bezeichnung
- gdf15
-
Hintergrund
- Macrophage inhibitory cytokine-1 (MIC-1) is a member of the transforming growth factor-ß superfamily that regulates a wide variety of physiological processes involved in tissue differentiation and maintenance (1). MIC-1 is synthesized as a 62- kDa intracellular protein, which, after cleavage by a furin like protease, is secreted as a 25- kDa disulphide-linked dimeric protein. Expression of MIC-1 results in inhibition of macrophage activation, regulated by the p53 pathway, in response to pro-inflammatory monokines (1,2). MIC-1 is involved in tumour pathogenesis and its measurement can be used as a clinical tool for the diagnosis of a wide range of cancers. It could be a useful marker for aggressive prostate cancer while MIC-1 is upregulated in advanced and more aggressive prostatic tumours (3).
-
UniProt
- Q99988
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-